- Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance
- Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China
- Cosmo and Sun Pharma Announce Territory Expansion of License and Supply Agreements for WINLEVI® to include Japan, Australia, New Zealand, Brazil, Mexico and Russia
- Cosmo announces acceptance of NDA submission of Cortiment® MMX® in Japan
Cosmo Pharmaceuticals NV (C43:DEU) closed at 49.80, 23.27% above the 52 week low of 40.40 set on Jun 15, 2022.
40.40Jun 15 202276.00Sep 23 2021
Markit short selling activity
|Market cap||823.58m CHF|
|EPS (TTM)||1.80 |
|Annual div (ADY)||0.95 |
|Annual div yield (ADY)||1.91%|
|Div ex-date||Jun 01 2022|
|Div pay-date||Jun 03 2022|
Data delayed at least 15 minutes, as of Sep 23 2022 16:37 BST.